NCT06839105 2025-05-31
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Recruiting
Shanghai Junshi Bioscience Co., Ltd.
Eli Lilly and Company
M.D. Anderson Cancer Center